School of Medicine
Showing 201-250 of 360 Results
-
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology
Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Antonio Meola, MD, PhD
BioAntonio Meola M.D. Ph.D graduated Summa cum Laude and Research Honors at the University of Pisa, Italy, in 2008, and completed his residency training in Neurosurgery at the same Institution in July 2015. Dr Meola attended a Ph.D. program at the University of Florence, Italy, where he discussed a doctoral thesis entitled "A New Head-Mounted Display-based Augmented Reality System in Neurosurgical Oncology: a study on phantom".
Since 2/2014 to 1/2015 Dr Meola completed a Research Fellowship in Neurosurgical anatomy at the University of Pittsburgh Medical Center (UPMC), under the Direction of Dr. Juan C. Fernandez-Miranda. The main focus of his research was the surgical neuroanatomy of the white matter tracts of the human brain.
Since 7/2015 to 6/2016 Dr Meola served as Clinical Fellow in Image-Guided Neurosurgery at the Brigham and Women's Hospital, Harvard Medical School, in Boston, MA (Director: Dr. Alexandra J. Golby M.D.). During the fellowship, he focused on the clinical application and integration of advanced imaging techniques, including intraoperative-MRI, intraoperative US, functional MRI, tractography.
Since 7/2016 to 6/2017 Dr Meola completed a Neurosurgical Oncology Fellowship at the Cleveland Clinic in Cleveland, OH, devoting his efforts to minimally-invasive neurosurgical techniques, such as Laser interstitial Thermal Therapy (LITT) and stereotactic radiosurgery (Gamma Knife), as well as to awake neurosurgery.
Starting 7/2017, Dr Meola joined the Department of Neurosurgery at Stanford. Dr. Meola mainly focuses on conventional and innovative treatments for brain and skull base tumors, including both surgery and stereotactic radiosurgery (CyberKnife). -
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Anna H. Messner, MD
Professor of Otolaryngology-Head and Neck Surgery (Pediatrics) at the Stanford University Medical Center and the Lucile Salter Packard Children's Hospital, Emerita
Current Research and Scholarly Interests-- Obstructive sleep apnea in children
-- Postoperative tonsillectomy care
-- Ankyloglossia
-- Medical Education -
Ross Metzger
Senior Research Scientist, Pediatrics - Cardiology
Current Research and Scholarly InterestsDevelopment, maintenance, and repair of the pulmonary circulation
-
Everett Meyer
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy), of Pediatrics (Stem Cell Transplantation) and, by courtesy, of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
Timothy Meyer
Stanford University Professor of Nephrology, Emeritus
Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
-
Sara Michie
Professor of Pathology (Research), Emerita
Current Research and Scholarly InterestsLymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.
-
Mitchell Miglis, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep MedicineCurrent Research and Scholarly InterestsProdromal markers of neurodegeneration in REM sleep behavior disorder
Autonomic dysfunction in Long-COVID
Postural tachycardia syndrome -
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology
Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis (deep learning), and immunology (narcolepsy is an autoimmune disease of the brain). We also work on autoimmune encephalitis.
-
Frederick Mihm, M.D.
Professor of Anesthesiology, Perioperative and Pain Medicine (ICU)
On Leave from 07/01/2024 To 08/06/2024Current Research and Scholarly InterestsDr. Mihms two areas of research interest involve cardiorespiratory monitoring techniques and applications and the perioperative management of patients with pheochromocytoma.
-
Lekha Mikkilineni
Assistant Professor of Medicine (Blood and Marrow Transplantation & Cellular Therapy)
BioDr. Lekha Mikkilineni is a board-certified medical oncologist. She is also an Assistant Professor in the Department of Medicine, Division of Blood & Marrow Transplant and Cellular Therapy.
Dr. Mikkilineni has extensive experience treating blood and bone marrow cancers. She currently provides care through the Bone Marrow Transplant & Cellular Therapy Program at Stanford Health Care. Her clinical focus is multiple myeloma, plasma-cell leukemia, Extramedullary myeloma, high-risk myeloma, CAR T cell therapy, bispecific therapy, amyloidosis, POEMS syndrome, and Waldenstrom’s macroglobunemia.
Dr. Mikkilineni’s research centers on exploring novel CAR T-cell therapies to treat multiple myeloma and to define mechanisms of resistance to immunotherapy. She is particularly focused on understanding how to improve therapies for multiple myeloma patients who have extramedullary disease or high-risk features. Prior to coming to Stanford, she ran phase 1 CAR T-cell trials for multiple myeloma targeting BCMA and SLAMF7 at the National Cancer Institute.
Dr. Mikkilineni received the Conquer Cancer Foundation Young Investigator Award from the American Society of Clinical Oncology for her research focusing on SLAMF7 as a potential target for multiple myeloma. She has received honors and awards for her work at the NCI. She has completed fellowships in hematology/oncology and immunotherapy at the National Heart, Lung, and Blood Institute/National Cancer Institute. She finished her residency in internal medicine at Thomas Jefferson University Hospital. She holds a Master of Science in medical sciences from Boston University and a medical degree from Tulane University.
Dr. Mikkilineni has authored book chapters and published research in numerous high-impact academic journals. She has presented her findings through oral and poster presentations at national and international conferences. -
David Miklos
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Miklos is the Chief of BMT & Cell Therapy Program. He leads clinical trials treating patients with lymphoma. His correlative research studies: 1) tumor antigen quantification, 2) single cell functional product characterization, 3) CAR-FACS immune phenotyping of blood and tumor, and identifying mechanisms for CAR-T treatment Failure including antigen loss, CAR-T exhaustion, and CAR suppression.
-
Amin Milki, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsInfertility
Assisted Reproductive Technologies Microsurgery and Endoscopic Surgery. -
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
Robert S. Millard, MD
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Robert Millard is board certified in Physical Medicine and Rehabilitation. He Is fellowship trained in Interventional spine care and Sports Medicine. Prior to joining Stanford, he was in private practice for 27 years. Dr. Millard’s medical practice involves the treatment of spine pain syndromes and Sports injuries. Interventional spine procedures performed by Dr. Millard include cervical/lumbar: transforaminal epidural injections; facet injections; medial branch blocks and radio frequency ablation (rhizotomies). He has served as team physician for the San Francisco 49ers (1992-2008) and the San Jose Sharks (2005-2015).
-
D. Craig Miller, M.D.
Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus
Current Research and Scholarly InterestsCardiac and heart valve disease with experimental laboratory large animal projects focused on the investigation of left ventricular and cardiac mechanics, bioenergetics, and LV and mitral valve physiology and pathophysiology. Current thrust is aimed at understanding the mitral valve and subvalvular mitral apparatus and transmural LV wall strains, thickening, and myolaminar fiber-sheet mechanics.
Clinical research interests include thoracic aortic diseases (aortic dissection, aneurysm) and cardiac valvular disease, including surgical treatment, endovascular thoracic aortic stent-graft repair, mitral valve repair, and valve-sparing aortic root replacement. -
Matt Miller, MD
Clinical Associate Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsMy current research interests include operative and non-operative treatment of arthritis, minimally invasive techniques for hip and knee replacement, clinical outcomes of joint replacement surgery, and the design of hip and knee implants and instrumentation.
-
Travis Miller, MD
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Travis Miller is a fellowship-trained plastic and reconstructive surgeon at Stanford Health Care. He is a Clinical Assistant Professor in the Department of Surgery, Division of Plastic & Reconstructive Surgery at Stanford University School of Medicine.
Dr. Miller specializes in plastic surgery from head to toe with additional training in hand and microsurgery. He treats a multitude of conditions of the hand and upper extremity, including carpal tunnel syndrome, trigger finger, hand and wrist fractures, wrist pain and instability, arthritis, cubital tunnel syndrome, Dupuytren’s, and brachial plexus injury. He specializes in complex reconstruction all over the body using both local tissues and free tissue transfer. He has a special interest in peripheral nerve surgery, including treating nerve compression syndromes, tumors, traumatic injuries, amputation pain, neuromas, and migraines. He also performs aesthetic surgery, and for all his patients he strives to achieve their functional and cosmetic goals.
Dr. Miller received his medical degree from the University of Texas Southwestern Medical School where he graduated first in his class. He completed his residency in plastic and reconstructive surgery through Stanford University School of Medicine. Before pursuing a fellowship in Hand and Microsurgery at the University of Washington, he also completed an in-residency fellowship at the Buncke Clinic in San Francisco, widely considered the birthplace of microsurgery.
Dr. Miller has an extensive research background. He collaborated with a team that invented and patented a medical device used for coiled surgical tools and catheters. In addition to book chapters and monographs, he has written numerous peer-reviewed journal manuscripts that have been published in journals such as The Journal of Hand Surgery, The Journal of Surgical Oncology, Microsurgery, and Plastic and Reconstructive Surgery. Dr. Miller has presented his research at regional, national, and international meetings. -
Rebecca Kate Miller-Kuhlmann
Clinical Associate Professor, Neurology & Neurological Sciences
BioRebecca Miller-Kuhlmann, MD is board certified in Neurology and in Electrodiagnostic Medicine and practices as a Clinical Associate Professor of Neurology & Neurological Sciences at Stanford University. She earned her MD from UCSF School of Medicine and completed residency and fellowship training at Stanford University. Her fellowship training in Comprehensive Clinical Neurology focused on movement disorders, memory/cognitive disorders neuromuscular medicine/EMG/NCS studies, and therapeutic applications of botulinum toxin with supplementary training in headache, epilepsy and neuroimmunology. Her clinical focus is diagnosis and treatment of neurologic conditions with commitment to maintaining a wide-breadth of knowledge in order to best treat complex patients with multiple neurologic issues.
Academically, Dr Miller-Kuhlmann is passionate about medical education and physician wellbeing. Prior to her career in medicine, Dr Miller-Kuhlmann was a public school teacher in Oakland, CA. She completed the UCSF health professions education pathway with a dean's award for research in medical student reflection during medical school. During residency she served as education chief resident and earned an honors certificate in medical education at Stanford, She continues to enjoy working with medical students and residents in the clinic as well as the classroom. She directs the Science of Medicine course which covers physiology and pathology of each organ system for first and second year medical students, and as of 2023 has had the priviledge to serve as the Assistant Dean for Preclerkship Education. At the residency level, she serves as the associate-director for a novel communication coaching program within the Stanford Neurology Residency.
Dr. Miller-Kuhlmann is the Wellbeing Director for the Department of Neurology and interested in multi-level strategies for promotion of professional fulfillment and mitigation of physician burnout. Nationally, she was an inaugural graduate of the American Academy of Neurology's Live Well Lead Well Leadership programs, serves on the AAN physician wellness subcommittee, and has had the opportunity to speak on physician wellbeing at the AAN annual meeting. Locally, she co-developed a wellbeing program for neurology residents and fellows, steers the neurology department wellness committee, and through close partnership with department quality improvement leaders serves on projects to improve physician wellbeing through a focus on system supports and efficiencies. To this end, she is also a graduate of the Stanford Clinical Effectiveness Leadership Program which develops skills in quality improvement and change management. She also co-developed and annually teaches a project-based novel quality improvement curriculum for residents with an eye toward empowering and supporting trainees in becoming agents of change within the system. -
Leah S. Millheiser, MD, FACOG, NCMP
Clinical Professor, Obstetrics & Gynecology - General
Current Research and Scholarly InterestsResearch interest in the role of the central nervous system in female hypoactive sexual desire disorder.
-
Lynn Million
Clinical Professor, Radiation Oncology - Radiation Therapy
BioLynn Million specializes in the treatment of cancer. She has practiced Radiation Oncology for more than 30 years. Dr. Million has a special interest in the treatment of sarcoma’s of soft tissue, bone and cartilage in children, young adolescents and adults.
-
Arnold Milstein
Professor of Medicine (General Medical Discipline)
Current Research and Scholarly InterestsDesign national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.
Research on creation of a national index of health system productivity gain. -
Robert Mindelzun
Professor of Radiology at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsAbdominal imaging,
Anatomy.
Mesenteries, peritoneum, omentum, pancreatic anatomy and embryology.
Third World diseases.
Abdominal trauma. -
Lloyd B. Minor, MD
The Carl and Elizabeth Naumann Dean of the School of Medicine, Vice President for Medical Affairs, Stanford University, Professor of Otolaryngology - Head and Neck Surgery and Professor of Neurobiology and of Bioengineering, by courtesy
Current Research and Scholarly InterestsThrough neurophysiological investigations of eye movements and neuronal pathways, Dr. Minor has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning. Following his discovery of superior canal dehiscence, he published a description of the disorder’s clinical manifestations and related its cause to an opening in the bone covering of the superior canal. He subsequently developed a surgical procedure to correct the problem.
-
Vijay Mirmira
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Mirmira believes that excellent communication leads to excellent care, and is dedicated to the health and well-being of his patients and their families. He is fluent in English, Hindi, Tamil and Kannada and has working knowledge of Urdu and Telugu. Apart from enjoying practicing the full scope of family medicine, Dr. Mirmira's special interests include diabetes and thyroid disorders, and pediatric illnesses. He likes to travel and read fiction in his free time.
-
Paul Salomon Mischel
Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.
-
Kavita Mishra
Clinical Assistant Professor, Obstetrics & Gynecology
BioDr. Kavita Mishra is a board-certified urogynecologist who specializes in transgender surgery and the treatment of pelvic floor disorders. She has specific training in gender-affirming vaginoplasty, pelvic organ prolapse, and urinary and fecal incontinence. She has expertise in vaginal and minimally invasive reconstructive pelvic surgery, including laparoscopic and robotic approaches.
-
Tsuyoshi (Yoshi) Mitarai
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsCritical Care, optimal resource allocations for inpatient care
-
Beverly S. Mitchell, M.D.
George E. Becker Professor of Medicine
Current Research and Scholarly InterestsBeverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.